PV EAEU 1969
Way back in the former USSR, the Department of registration, systematization and expedited reporting of drug side effects pioneered drug efficacy and safety monitoring.
2001
Biomapas is established and conducts its first BE studies
2002
Phase I-IV Clinical Trials are initiated
2003
First studies performed in the CIS region.
2004
First PK/PD Studies with Biologicals/Biosimilars.
2005
The Pharmacovigilance department is established.
2009
The Regulatory Affairs department is established.
2011
Biomapas adds Medical Devices services to its portfolio and completes first projects.
2012
Biomapas completes the ISO 9001:2008 to ensure high-quality services for its clients.
2013
The launch of Clinical Safety and Medical Monitoring services
2014
New offices open up in Russia and Georgia.
2015
New office opens up in Switzerland.
2016
New office opens up in Ukraine.
2017
Integrated ISO 9001:2015 and ISO 13485:2016
2018
New office opens up in Sweden.
2019
New office opens up in Poland.
2020
New office opens up in Kazakhstan.
2020
Biomapas adds Medical Information to its portfolio and consolidates its position as a partner from Early development to Post-Marketing.
World Drug Safety Congress Europe
Let’s meet at the World Drug Safety Congress Europe 2023, an exciting drug safety safety event in Amsterdam, Netherlands.
SwedenBIO Summit
Meet us at the international partnering event to discuss the key challenges in clinical development in December in Stockholm.
